Literature DB >> 11841621

Emerging targets: molecular mechanisms of cell contact-mediated growth control.

Peter J Nelson1, Thomas O Daniel.   

Abstract

Contact inhibition of cell proliferation evokes a unique cellular program of growth arrest compared with stress, age, or other physical constraints. The last decade of research on genes activated by cell-cell contact has uncovered features of transmembrane signaling, cytoskeletal reorganization, and transcriptional control that initiate and maintain a quiescent phenotype. This review will focus on mechanisms controlling contact inhibition of cell proliferation, highlighting specific gene expression responses that are activated by cell-cell contact. Although a temporal framework for imposition of these mechanisms has not yet been well described, contact inhibition of cell proliferation clearly requires their coordinated function. Novel targets for intervention in proliferative disorders are emerging from these studies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11841621     DOI: 10.1046/j.1523-1755.2002.0610s1099.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  20 in total

1.  Adipose tissue-organotypic culture system as a promising model for studying adipose tissue biology and regeneration.

Authors:  Shuji Toda; Kazuyoshi Uchihashi; Shigehisa Aoki; Emiko Sonoda; Fumio Yamasaki; Meihua Piao; Akifumi Ootani; Nobuhisa Yonemitsu; Hajime Sugihara
Journal:  Organogenesis       Date:  2009-04       Impact factor: 2.500

2.  Cell density-dependent reduction of dihydroceramide desaturase activity in neuroblastoma cells.

Authors:  Stefka D Spassieva; Mehrdad Rahmaniyan; Jacek Bielawski; Christopher J Clarke; Jacqueline M Kraveka; Lina M Obeid
Journal:  J Lipid Res       Date:  2012-02-29       Impact factor: 5.922

3.  GDNF enhances human blood-nerve barrier function in vitro via MAPK signaling pathways.

Authors:  Chaoling Dong; Eroboghene E Ubogu
Journal:  Tissue Barriers       Date:  2018-12-07

4.  Merging high-quality biochemical fractionation with a refined flow cytometry approach to monitor nucleocytoplasmic protein expression throughout the unperturbed mammalian cell cycle.

Authors:  Margit Rosner; Katharina Schipany; Markus Hengstschläger
Journal:  Nat Protoc       Date:  2013-02-28       Impact factor: 13.491

5.  Tumor suppressor density-enhanced phosphatase-1 (DEP-1) inhibits the RAS pathway by direct dephosphorylation of ERK1/2 kinases.

Authors:  Francesca Sacco; Michele Tinti; Anita Palma; Emanuela Ferrari; Aurelio P Nardozza; Rob Hooft van Huijsduijnen; Takamune Takahashi; Luisa Castagnoli; Gianni Cesareni
Journal:  J Biol Chem       Date:  2009-06-03       Impact factor: 5.157

6.  E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases.

Authors:  Xiaolan Qian; Tatiana Karpova; Allan M Sheppard; James McNally; Douglas R Lowy
Journal:  EMBO J       Date:  2004-04-01       Impact factor: 11.598

7.  Mouse EP3 alpha, beta, and gamma receptor variants reduce tumor cell proliferation and tumorigenesis in vivo.

Authors:  Ines M Macias-Perez; Roy Zent; Monica Carmosino; Matthew D Breyer; Richard M Breyer; Ambra Pozzi
Journal:  J Biol Chem       Date:  2008-01-29       Impact factor: 5.157

8.  PIASy represses CCAAT/enhancer-binding protein delta (C/EBPdelta) transcriptional activity by sequestering C/EBPdelta to the nuclear periphery.

Authors:  Shanggen Zhou; Junling Si; Tong Liu; James W DeWille
Journal:  J Biol Chem       Date:  2008-05-12       Impact factor: 5.157

9.  Hypersensitivity to contact inhibition provides a clue to cancer resistance of naked mole-rat.

Authors:  Andrei Seluanov; Christopher Hine; Jorge Azpurua; Marina Feigenson; Michael Bozzella; Zhiyong Mao; Kenneth C Catania; Vera Gorbunova
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-26       Impact factor: 11.205

10.  Restoration of contact inhibition in human glioblastoma cell lines after MIF knockdown.

Authors:  Jörg Schrader; Oliver Deuster; Birgit Rinn; Martina Schulz; Andreas Kautz; Richard Dodel; Bernhard Meyer; Yousef Al-Abed; Karthikeyan Balakrishnan; Jens P Reese; Michael Bacher
Journal:  BMC Cancer       Date:  2009-12-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.